The city of Nashville, Tennessee, currently has 313 active clinical trials seeking participants for Cancer research studies.
Hypofractionated Image Guided Proton Therapy for Low andIntermediate Risk Prostate Cancer
Recruiting
This study is being proposed to evaluate the use of moderate hypofractionated proton therapy in low and intermediate risk prostate cancer patients. Quality of life outcomes as well as gastrointestinal and genitourinary early and late toxicities will be analyzed and compared to conventional proton therapy regimens. It is thought that this regimen will produce comparable findings and would result in substantial health care cost savings, as well as, be more convenient for patients.
Gender:
MALE
Ages:
18 years and above
Trial Updated:
04/03/2019
Locations: Provision Cares Proton Therapy Center Nashville, Nashville, Tennessee
Conditions: Prostate Cancer